Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
79,892.00
Year-over-Year Change
28.24%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks long-term bank loans for pharmaceutical and medicine corporations in the United States. It provides critical insight into the debt financing strategies and capital structures of a key healthcare industry sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the total value of bank loans with maturities exceeding one year for U.S. pharmaceutical companies. Economists use this indicator to assess corporate financial health, investment capacity, and potential expansion strategies in the pharmaceutical sector.
Methodology
Data is collected quarterly through comprehensive financial reporting and aggregated by the U.S. Federal Reserve from corporate financial statements.
Historical Context
This trend is used by policymakers, investors, and financial analysts to evaluate the pharmaceutical industry's financial stability and potential for research and development investment.
Key Facts
- Reflects long-term financial commitments in the pharmaceutical sector
- Indicates corporate borrowing capacity and financial strategy
- Provides insights into industry investment and expansion potential
FAQs
Q: What does this trend measure?
A: It measures long-term bank loans for U.S. pharmaceutical and medicine corporations with maturities over one year.
Q: Why are these loans important?
A: These loans enable pharmaceutical companies to fund research, development, and expansion of critical healthcare technologies and treatments.
Q: How often is this data updated?
A: The data is collected and updated quarterly by the U.S. Federal Reserve through the Quarterly Financial Report.
Q: How do investors use this information?
A: Investors analyze this trend to assess the financial health, borrowing capacity, and potential growth of pharmaceutical corporations.
Q: What are the limitations of this data?
A: The trend only captures bank loans and does not include other forms of financing like equity or bonds, providing a partial view of corporate financing.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Machinery: Inventories
QFR214333USNO
Quarterly Financial Report: U.S. Corporations: Basic Chemicals, Resins, and Synthetics: Trade Accounts and Trade Notes Payable
QFR306375USNO
Quarterly Financial Report: U.S. Corporations: Electrical Equipment, Appliances, and Components: Income (Loss) from Operations
QFR104335USNO
Quarterly Financial Report: U.S. Corporations: Furniture and Related Products: Other Short-Term Financial Investments
QFRD210337USNO
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial Paper
QFRD304385USNO
Quarterly Financial Report: U.S. Corporations: Nonmetallic Mineral Products: Retained Earnings at End of Quarter
QFRD123327USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Loans from Banks [QFR316385USNO], retrieved from FRED.
Last Checked: 8/1/2025